Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lupus Erythematosus, Systemic × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 107 Breast Neoplasms 64 Neoplasms 44 Prostatic Neoplasms 18 Obesity 14 Fatigue 13 Lung Neoplasms 11 Colorectal Neoplasms 11 Polycystic Ovary Syndrome 9 Colonic Neoplasms 8 Head and Neck Neoplasms 7 Weight Loss 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Inflammation 5 Overweight 4 Multiple Myeloma 4 Lymphedema 4 Leukemia, Myeloid, Acute 4 Leukemia 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Multiple Endocrine Neoplasia Type 1 3 Lymphoma, Follicular 3 Lymphoma 3 Insulin Resistance 3 Depression 3 Cardiotoxicity 3 Carcinoma, Non-Small-Cell Lung 3

Interventions

sotrovimab 1 ciclesonide 1 Niclosamide 1 High-Intensity Interval Training 1 Exercise 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05478018 2025-09-09

LUPEX

Rigshospitalet, Denmark

Phase NA Completed

Lupus Erythematosus, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡